Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-08-000214
Filing Date
2008-02-11
Accepted
2008-02-11 17:12:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 ENZON INC. emzo1231f.htm SC 13G 33779
  Complete submission text file 0000019617-08-000214.txt   36336
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 39TH FL NEW YORK NY 10017 2122706000
J P MORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 08594511
SIC: 2836 Biological Products, (No Diagnostic Substances)